论文信息 - Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16) - 字舞流文

Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16)

Dong Sook Kim | S. Park | Keun-Wook Lee | S. Sym | M. Ryu | S. Rha | D. Oh | J. Byun | W. Bae | Y. Suh | H. Jee | Inho Kim | Jong Gwang Kim | H. An | H. Kim | B. Kim | D. Zang | H. Han | S. Oh | S. Oh